Location: Home
  • search
  • go
  • Relate News
  • 7/12/2019Review of Drug Applications Accepted for Priority Review Since Incepti...
  • 7/12/2019Takeda Files NDA for Entyvio (Vedolizumab) in China
  • 7/12/2019Novartis Files NDA for Second Indication of Dabrafenib/Trametinib in C...
  • 7/11/2019Gilead Sciences to Establish Its Western China Operation Center in Che...
  • 7/11/2019111 and Eli Lilly Enter Partnership for Distribution of Cialis Thru th...
  • 7/11/2019Leading Chinese Neurosurgery Hospital Publishes Brain Tumor Database
  • 7/10/2019MacroGenics and I-Mab Announce Collaboration and License Agreement for...
  • 7/10/2019China NT Pharma Group To Buy 40% Stake In Hong Kong WD Pharma
  • 7/10/2019NHSA Proposes New Rule to Regulate Drug Prices
  • 7/10/2019SAMR Releases Draft Regulation for Serious Violations and Bad Credits
  • 7/10/2019CDE Publicizes Three More Drug Applications To Be Granted Priority Rev...
  • 7/10/2019NHC: All Poor Rural Areas to Get Basic Healthcare Access
  • 7/9/2019IQVIA: Chinese Hospital Drug Market Up 4.3% in MAT Q1/2019
  • 7/9/2019Priority Review Granted to BeiGene’s Supplemental NDA in China for Ti...
  • 7/9/2019Trade Tensions Undermines Flow of Chinese VC to US Biotechs
  • 7/9/2019China Accounted for 67% of India's Bulk Drug Imports in FY19
  • 7/9/2019CDE Reports 47% Increase with Drug Applications in 2018
  • 7/9/20192019 Rubio's Huawei Proposal Should Worry US Tech, Pharma Companies
  • 7/9/2019UCSD Doctor Resigns After inewsource Raised Questions About His China ...
  • 7/9/2019Fosun Pharma Picks Up GSK Plant in China along with Rights to Make Epi...
  • 7/9/2019U.S. Seeks Extradition of Chinese Scientist in GSK Trade Secrets Case
  • 7/8/2019Pfizer Launches Anticancer VIZIMPRO (dacomitinib) following Chinese A...
  • 7/5/2019Recent Executive Moves
  • 7/5/2019Syncore Set to Initiate Phase III Trial of Cancer Drug
  • 7/5/2019Novartis Eyes Registration of 50 New Drugs in China Before 2023
  • 7/5/2019China Approves Janssen‘s Anticancer DARZALEX (Daratumumab)
  • 7/5/2019CDE Seeks Comments on Draft ICH Guideline E8(R1)
  • 7/5/2019China Launches Pilot Mental Healthcare Program for Senior Citizens
  • 7/4/2019China Approves Alteogen’s Herceptin Biosimilar for Clinical Trials
  • 7/4/2019Incyte and Zai Lab Announce Collaboration and License Agreement for IN...
  • Page:290/790 Total number of articles:23683: [First][<<] [288] [289] [290] [291] [292] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group